CONMED vs LeMaitre Vascular
CONMED reported revenue of $1.4 billion in fiscal 2025, 5.5 times LeMaitre Vascular's $250 million in fiscal 2025. CONMED's revenue grew 5.2% in its latest year, and LeMaitre Vascular's grew 13.5%. CONMED had an operating margin of 7.5%, against 27.2% at LeMaitre Vascular. Free cash flow was $151 million at CONMED and $74 million at LeMaitre Vascular.
Side by side
| CONMED | LeMaitre Vascular | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.4B | $250M |
| Revenue growth | 5.2% | 13.5% |
| Revenue growth a year, last 5 years | 9.8% | 14.0% |
| Gross margin | 54.6% | 71.5% |
| Operating margin | 7.5% | 27.2% |
| Net margin | 3.4% | 23.1% |
| Free cash flow | $151M | $74M |
| Free cash flow margin | 11.0% | 29.8% |
| Return on capital | 3.7% | 25.5% |
| Net debt to EBITDA | 5.1x | −2.4x |
| Dividends and buybacks | $25M | $20M |
| Change in diluted share count | −0.0% | 0.7% |
| Last close | $47.68 | $84.31 |
| P/E at the last close | 31.6× | 29.6× |
| Insider trades, last 12 months | sold $161,091 | sold $30.0 million |
| Piotroski F-score | 6 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CONMEDLeMaitre Vascular
Operating margin
Percent of revenue
CONMEDLeMaitre Vascular
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CONMEDLeMaitre Vascular
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CONMED and LeMaitre Vascular pages.